Genetic testing helps uncover inherited health risks and conditions that may run in your family. At Bids Chemist, our DNA tests provide valuable insight into how your genes influence health, metabolism, and disease likelihood. This understanding supports personalised prevention, early detection, and personalised wellness plans for long-term wellbeing.
This test analyses apolipoprotein E genotype, identifying the E2, E3, and E4 variants that affect cholesterol transport and cardiovascular or neurological risk. Blood is collected, and results help healthcare providers evaluate genetic predisposition to cardiovascular disease, Alzheimer’s disease, and lipid metabolism disorders. Understanding apolipoprotein E genotype supports personalised preventive strategies, lifestyle planning, and early intervention. Patients gain insight into their genetic profile, enabling informed health decisions for heart and cognitive wellbeing.
This genetic panel sequences 14 genes related to breast cancer, detecting mutations or deletions that increase cancer risk. Blood or saliva is collected, and advanced sequencing identifies hereditary predisposition. Results allow healthcare providers to assess personal and family risk, guide screening strategies, preventive measures, and personalised treatment planning. Patients benefit from understanding genetic risk, enabling early intervention, targeted surveillance, and informed lifestyle or medical decisions to reduce long-term cancer risk and improve overall outcomes.
This genetic test identifies HLA DQ2 and DQ8 genotypes, which are associated with coeliac disease. Blood is drawn and analysed to determine genetic predisposition. Presence of these genes increases the risk of developing gluten intolerance, autoimmune reactions, or intestinal inflammation. Early detection helps healthcare providers guide dietary modifications, monitoring, and preventive care. Patients benefit by understanding their genetic risk, managing gluten intake proactively, and reducing the likelihood of complications such as nutrient deficiencies or gastrointestinal symptoms.
This test examines chromosomes in blood cells to detect genetic abnormalities such as extra, missing, or structurally altered chromosomes. Blood is collected and cells are cultured, then analysed under a microscope to evaluate chromosomal number and structure. Results can help diagnose congenital disorders, infertility issues, recurrent miscarriages, or certain blood cancers. Early detection enables healthcare providers to offer genetic counseling, guide treatment options, and provide reproductive planning advice. Patients benefit by understanding their genetic profile, identifying potential health risks, and taking proactive steps to manage long-term health and family planning decisions. Accurate karyotyping supports informed medical care and preventive strategies.
This test identifies Factor II (Prothrombin) G20210A mutation, a genetic variation that increases blood clot risk. Blood is collected and analysed to assess thrombophilia, which may lead to deep vein thrombosis, pulmonary embolism, or pregnancy complications. Early detection allows healthcare providers to implement preventive measures, monitor risk, and guide therapy. Patients benefit from understanding genetic predisposition, managing clotting risk, and protecting long-term vascular health.
This test detects Factor V Leiden mutation, a genetic variation that increases the risk of blood clots. Blood is collected and analysed to evaluate thrombophilia risk. Early detection allows healthcare providers to implement preventive measures, monitor for clot formation, and guide therapy. Patients benefit by understanding genetic risk, taking proactive measures, and protecting cardiovascular and vascular health.
This non-invasive prenatal test screens for chromosomal abnormalities, including trisomies 21, 18, and 13, using a blood sample from the mother. The test analyses fetal DNA fragments circulating in maternal blood to assess genetic risk. Results are highly accurate and allow early detection of potential conditions, helping healthcare providers counsel parents, guide further testing, and support pregnancy planning. Patients benefit from a safe, reliable method to assess fetal health, reduce uncertainty, and make informed decisions. Early results enable timely medical advice, monitoring, and preparation for specialised care if needed, ensuring better outcomes for both mother and baby.
Genetic test detecting mutations associated with hereditary haemochromatosis, a condition causing iron overload in the body. Helps identify individuals at risk of liver damage, diabetes, heart disease, or joint problems due to iron accumulation. Blood is collected for DNA analysis, and results guide preventive measures, monitoring, and early interventions. Detecting HFE mutations also allows family members to be assessed for risk. Understanding results empowers patients to manage iron intake, undergo therapeutic phlebotomy if needed, and reduce complications over time.
This genetic test identifies common variants in the MTHFR gene, which can affect folate metabolism and homocysteine levels. Blood is collected and analysed to assess genetic risk factors for cardiovascular disease, pregnancy complications, or metabolic disorders. Results help healthcare providers guide dietary recommendations, supplementation, and preventive strategies. Patients benefit by understanding their genetic predisposition, optimising nutrient metabolism, supporting cardiovascular health, and preventing long-term complications. Early identification enables personalised interventions and long-term wellness planning.
